Category: Corona Virus

Page 321«..1020..320321322323..330340..»

Maine leads the nation in second COVID-19 booster shots, Shah says – Press Herald

May 30, 2022

Maine is the first state to see at least 30 percent of its eligible population receive a second COVID-19 booster shot, according to Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention.

Maine once again lives up to our Dirigo motto, Shah tweeted Friday, noting that the state leads the nation in second booster shots with a rate of 30.5 percent of those eligible.

Adults 50 years and older, and people who are immunocompromised, may receive a second booster, according to the U.S. Centers for Disease Control and Prevention.

Of Maines 1.34 million population, 74.23 percent have been fully vaccinated, and 756,933 doses of booster shots had been administered as of Saturday, according to the Maine CDC. The tally of booster doses does not break down how many people have been boosted, or whether they got first or second booster shots.

Meanwhile Sunday, the Maine CDC reported 162 people were hospitalized with the coronavirus. Of those, 20 were in critical care units and three on ventilators. Thats an improvement from Saturday, when 166 people were in hospitals statewide with the virus.

The state reported 475 new cases of COVID-19 Saturday, compared to 510 new cases on Friday. The true number of infections is underreported because many people who take at-home tests do not report results.

Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, said of those who are in indoor settings with large numbers of people without masks, there is a good likelihood you will suffer a breakthrough infection, The Washington Post reported on Sunday.

In Maine, with most counties now categorized by the U.S. CDC as being at medium or high risk of coronavirus transmission, if youre in a group of 25 people, it is likely that one of them is positive for COVID, said Dr. Dora Anne Mills, the chief health improvement officer for MaineHealth and former head of the Maine CDC.

If youre fully boosted, relatively healthy and not elderly, even if you contract COVID, the chances are it will be mild, though its hard to know what your chances are of contracting long haul COVID, Mills said Sunday in an email.

If someone wants to go to a movie or an indoor concert, Mills recommends being fully boosted, wearing a high-quality mask and sitting where the ventilation is better. She also recommends having a plan for how to access treatment if infected. The risk for severe COVID-19 illness goes up steadily from age 40 and over, and much more precipitously from age 65 and up, she said.

Personally, Mills said she would go to the movies with conditions.

I feel fine to go to the movies, but while the COVID incidence is still high, Im choosing show times that are less crowded, and Im wearing a high-quality mask, sitting away from others, and of course making sure Im up (on) my vaccinations, Mills said.

Since the pandemic began, Maine has recorded 262,572 cases of the virus and 2,346 deaths. The state typically does not report additional deaths and cases on Sundays and Mondays.

The death toll reported on Friday was one higher than Saturday. The reason is the state lowered the death toll by one after the Maine CDC reviewed and validated information submitted to the agency, Robert Long of the Maine CDC said Sunday in an email. One death previously reported as a COVID-related death did not meet the criteria to be classified as such, Long said.

Invalid username/password.

Please check your email to confirm and complete your registration.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.

Previous

Read the rest here:

Maine leads the nation in second COVID-19 booster shots, Shah says - Press Herald

Arkansas governor reflects on past coronavirus pandemic response – KFSM 5Newsonline

May 28, 2022

Gov. Hutchinson opens up about how he led the state through the pandemic and what happened behind closed doors as he worked with world leaders to combat COVID-19.

ARKANSAS, USA In December 2019, the World Health Organization's (WHO) China office was alerted to several unknown origin pneumonia cases centered in Wuhan's seafood wholesale market.

At the time it didn't have a name, but it was the start of a deadly pandemic we now know as COVID-19.

Arkansas Governor Asa Hutchinson says he remembers being briefed on what was happening overseas.

"We had numerous calls with the White House, with other governors, helping to get prepared and helping to know how to respond to it," he said. "You knew that it was likely to come to Arkansas so you are trying to get prepared for it and nobody can really understand the gravity, the drama that was ahead for us."

According to the Centers for Disease Control & Prevention (CDC), the first laboratory case of COVID-19 was confirmed in the U.S. on January 20, 2020.

"It was actually shocking to see how quickly it spread in Washington state and how it hit the nursing homes. It was challenging in terms of hospital care, so it was alarm bells going off at that time," Hutchinson said of watching cases enter the U.S.

On March 11, 2020, Arkansas confirmed its first presumptive positive case. At the time, Gov. Hutchinson revealed the case came out of Pine Bluff, Arkansas.

"We had planned that when the first case hit that I would declare an emergency so we could put the resources needed to respond to it," he said.

Gov. Hutchinson says securing PPE was a challenge during a global shortage.

"It was unbelievable for me to be on the phone with our suppliers and saying we need to reserve factory time. I never thought I would have to do that as a Governor," he said. "And then being told we are being outbid by New York."

During the pandemic, the governor issued a directive to close indoor dining at restaurants. Later it extended to closing gyms, barbershops and salons for example.

"I remember the pressure even from the Trump Whitehouse to shelter in place, to close businesses. I resisted that in Arkansas, he explained. "It didn't make sense and so we didn't go down that path of saying, 'some businesses are essential, and some are non-essential.'"

The governor said all businesses are essential and he wanted to keep as many open as possible.

Closing school campuses in the spring of 2020 wouldn't last long. By the fall, virtual learning would be offered but many children headed back into the classroom.

"I was getting letters from female volleyball students saying, 'it's my senior year, please don't cancel our year.' The pressure was there because then you had some teachers protesting out in front of the mansion saying, 'you're going to put us in a coffin if you make us have school.' So, that was a lot of pressure," Gov. Hutchinson said.

5NEWS asked the governor if he has any regrets about how he handled the pandemic?

"One of the regrets is some of the confusing messages that were out there, and that science was disregarded," he explained. "Whenever you look at the skepticism over some of the vaccines, it just really surprised me. It was what we had been waiting for. All of a sudden, skepticism came in and they questioned that and conspiracy theories. I would have liked to have greater acceptance of that."

Hutchinson is term-limited and has served two four-year terms as governor and cannot run again.

5NEWS asked the governor what comes next? He said he is thinking about a run for president but did not say when he might decide on whether to enter the race.

As of May 27, 2022, Arkansas reported a total of 842,439 cases of COVID-19 since the beginning of the pandemic. 3,763 Arkansans have lost their lives to the virus in the past two years.

5NEWS ON SOCIAL MEDIA:Facebook | Twitter | Instagram | YouTube

HOW TO ADD THE 5NEWS APP TO YOUR STREAMING DEVICE

ROKU: add the channel from the ROKU store or by searching for KFSM in the Channel Store.

For Fire TV, search for "KFSM" to find the free app to add to your account. Another option for Fire TV is to have the app delivered directly to your Fire TV through Amazon.

To report a typo or grammatical error, please emailKFSMDigitalTeam@tegna.com.

See the original post here:

Arkansas governor reflects on past coronavirus pandemic response - KFSM 5Newsonline

Scientists Research People Who Have Never Been Infected By COVID-19 – NBC San Diego

May 28, 2022

According to the CDC, a majority of Americans have been infected by COVID-19 based on the antibodies showing up in their blood. Scientists can distinguish between COVID-19 antibodies that came from a previous infection and ones that came from the vaccine.

While many Americans have never tested positive, based on the antibodies, the CDC has determined that approximately 58% of Americans have been infected over the last two years. That number went up from 34% at the end of last year, which means that most Americans got infected during the Omicron surge.

Despite the high numbers, there are still many Americans who have never been infected by the coronavirus.

"I still think there are a lot of people who have perhaps been fortunate enough or privileged enough to be able to shelter themselves for the past two years who could very well still get it. Where they take a different approach to living their lives," said Dr. Jennifer Nuzzo, with Brown University's School of Public Health.

Now, scientists are trying to look at those who have never been infected to find out if there is something beyond luck and taking the right precautions, that make some people seemingly immune from getting infected.

"One of the things that should be looked at is whether people who were sort of in the same place, they had the same type of exposure, but some may have gotten it and some may have not and trying to understand what makes the ones who didnt get it, different," Nuzzo said.

Scientists at Rockefeller University in New York are currently studying that. Nuzzo says it's important to study these people because it could give scientists information about how to potentially prevent people from getting infected from the future, or possibly how to treat future variants of the virus.

"There was a hypothesis that some people may express a different level of the receptors, the types of cells that the virus tries to invade and that people with more of those may be more likely to be infected than people with fewer of those," she said.

As of right now, there have not been any conclusions regarding natural immunity from the coronavirus. Medical experts recommend continuing to take the proper precautions to prevent yourself from getting infected.

Go here to see the original:

Scientists Research People Who Have Never Been Infected By COVID-19 - NBC San Diego

In Massachusetts, new COVID-19 cases top 3,000 and 12 new deaths – Boston Herald

May 28, 2022

There were 3,092 new, confirmed cases of COVID in Massachusetts Wednesday and 12 new deaths, bringing the total number of lives claimed by the coronavirus to 19,404, according to the state Department of Public Health.

There also were 795 people hospitalized with COVID, and 79 people in intensive care units. Twenty-nine were intubated, that is, had a tube inserted into their trachea for ventilation.

The White House announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season.

The nations first federally backed test-to-treat site is opening Thursday in Rhode Island, providing patients with immediate access to the drug once they test positive. More federally supported sites are set to open in the coming weeks in Massachusetts and New York City, both hit by a marked rise in infections.

Next week, the U.S. will send authorized federal prescribers to several Minnesota-run testing sites, turning them into test-to-treat locations. Federal regulators have also sent clearer guidance to physicians to help them determine how to manage Paxlovids interactions with other drugs, with an eye toward helping prescribers find ways to get the life-saving medication to more patients.

Despite a nationwide surge in COVID-19 cases, deaths from the virus have remained largely stable over the past eight weeks, as vaccine booster shots and widely accessible treatments have helped to delink infections and mortality.

Confirmed infections in the U.S. have quadrupled since late March, from about 25,000 a day to more than 105,000 daily now. But deaths, which have tended to lag infections by three to four weeks over the course of the coronavirus pandemic, have declined steadily and are now plateaued at fewer than 300 per day.

Its the first time in the course of the pandemic that the two have not trended together, said White House COVID-19 coordinator Dr. Ashish Jha. He called it an important development in helping Americans get back to normal life.

The Associated Press contributes to this report.

Read the original here:

In Massachusetts, new COVID-19 cases top 3,000 and 12 new deaths - Boston Herald

You Are Going to Get COVID Again And Again And Again – The Atlantic

May 28, 2022

Two and a half years and billions of estimated infections into this pandemic, SARS-CoV-2s visit has clearly turned into a permanent stay. Experts knew from early on that, for almost everyone, infection with this coronavirus would be inevitable. As James Hamblin memorably put it back in February 2020, Youre Likely to Get the Coronavirus. By this point, in fact, most Americans have. But now, as wave after wave continues to pummel the globe, a grimmer reality is playing out. Youre not just likely to get the coronavirus. Youre likely to get it again and again and again.

I personally know several individuals who have had COVID in almost every wave, says Salim Abdool Karim, a clinical infectious-diseases epidemiologist and the director of the Center for the AIDS Program of Research in South Africa, which has experienced five meticulously tracked surges, and where just one-third of the population is vaccinated. Experts doubt that clip of reinfectionseveral times a yearwill continue over the long term, given the continued ratcheting up of immunity and potential slowdown of variant emergence. But a more sluggish rate would still lead to lots of comeback cases. Aubree Gordon, an epidemiologist at the University of Michigan, told me that her best guess for the future has the virus infiltrating each of us, on average, every three years or so. Barring some intervention that really changes the landscape, she said, we will all get SARS-CoV-2 multiple times in our life.

If Gordon is right about this thrice(ish)-per-decade pace, that would be on par with what we experience with flu viruses, which scientists estimate hit us about every two to five years, less often in adulthood. It also matches up well with the documented cadence of the four other coronaviruses that seasonally trouble humans, and cause common colds. Should SARS-CoV-2 joins this mix of microbes that irk us on an intermittent schedule, we might not have to worry much. The fact that colds, flus, and stomach bugs routinely reinfect hasnt shredded the social fabric. For large portions of the population, this is an inconvenience, Paul Thomas, an immunologist at St. Jude Childrens Research Hospital, in Tennessee, told me. Perhaps, as several experts have posited since the pandemics early days, SARS-CoV-2 will just become the fifth cold-causing coronavirus.

Or maybe not. This virus seems capable of tangling into just about every tissue in the body, affecting organs such as the heart, brain, liver, kidneys, and gut; it has already claimed the lives of millions, while saddling countless others with symptoms that can linger for months or years. Experts think the typical SARS-CoV-2 infection is likely to get less dangerous, as population immunity builds and broadens. But considering our current baseline, less dangerous could still be terribleand its not clear exactly where were headed. When it comes to reinfection, we just dont know enough, says Emily Landon, an infectious-disease physician at the University of Chicago.

Read: Coronavirus reinfection will soon become our reality

For now, every infection, and every subsequent reinfection, remains a toss of the dice. Really, its a gamble, says Ziyad Al-Aly, a clinical epidemiologist and long-COVID researcher at Washington University in St. Louis. Vaccination and infection-induced immunity may load the dice against landing on severe disease, but that danger will never go away completely, and scientists dont yet know what happens to people who contract mild COVID over and over again. Bouts of illness may well be tempered over time, but multiple exposures could still re-up some of the same risks as beforeor even synergize to exact a cumulative toll.

Will reinfection be really bad, or not a big deal? I think you could fall down on either side, says Vineet Menachery, a coronavirologist at the University of Texas Medical Branch. Theres still a lot of gray.

The majority of infections we witnessed in the pandemics early chapters were, of course, first ones. The virus was hitting a brand-new species, which had few defenses to block it. But people have been racking up vaccine doses and infections for years now; immunity is growing on a population scale. Most of us are no longer starting from scratch, says Talia Swartz, an infectious-disease physician, virologist, and immunologist at Mount Sinais Icahn School of Medicine. Bodies, wised up to the viruss quirks, can now react more quickly, clobbering it with sharper and speedier strikes.

Future versions of SARS-CoV-2 could continue to shape-shift out of existing antibodies reach, as coronaviruses often do. But the body is flush with other fighters that are much tougher to bamboozleamong them, B cells and T cells that can quash a growing infection before it spirals out of control. Those protections tend to build iteratively, as people see pathogens or vaccines more often. People vaccinated three times over, for instance, seem especially well equipped to duke it out with all sorts of SARS-CoV-2 variants, including Omicron and its offshoots.

Gordon, who is tracking large groups of people to study the risk of reinfection, is already starting to document promising patterns: Second infections and post-vaccination infections are significantly less severe, she told me, sometimes to the point where people dont notice them at all. A third or fourth bout might be more muted still; the burden of individual diseases may be headed toward an asymptote of mildness that holds for many years. Gordon and Swartz are both hopeful that the slow accumulation of immunity will also slash peoples chances of developing long COVID. An initial round of vaccine doses seems to at least modestly trim the likelihood of coming down with the condition, and the risk may dwindle further as defenses continue to amass. (We do need more data on that, Gordon said.)

Read: The pandemic after the pandemic

Immunity, though, is neither binary nor permanent. Even if SARS-CoV-2s assaults are blunted over time, there are no guarantees about the degree to which that happens, or how long it lasts. Maybe most future tussles with COVID will feel like nothing more than a shrimpy common cold. Or maybe theyll end up like brutal flus. Wherever the average COVID case of the future lands, no two peoples experience of reinfection will be the same. Some may end up never getting sick again, at least not noticeably; others might find themselves falling ill much more frequently. A slew of factors could end up weighting the dice toward severe diseaseamong them, a persons genetics, age, underlying medical conditions, health-care access, and frequency or magnitude of exposure to the virus. COVID redux could pose an especially big threat to people who are immunocompromised. And for everyone else, no amount of viral dampening can totally eliminate the chance, however small it may be, of getting very sick.

Long COVID, too, might remain a possibility with every discrete bout of illness. Or maybe the effects of a slow-but-steady trickle of minor, fast-resolving infections would sum together, and bring about the condition. Every time the bodys defenses are engaged, it takes a lot of energy, and causes tissue damage, Thomas told me. Should that become a near-constant barrage, thats probably not great for you. But Swartz said she worries far more about that happening with viruses that chronically infect people, such as HIV. Bodies are resilient, especially when theyre offered time to rest, and she doubts that reinfection with a typically ephemeral virus such as SARS-CoV-2 would cause mounting damage. The cumulative effect is more likely to be protective than detrimental, she said, because of the immunity thats laid down each time.

Al-Aly sees cause for worry either way. He is now running studies to track the long-term consequences of repeat encounters with the virus, and although the data are still emerging, he thinks that people who have caught the virus twice or thrice may be more likely to become long-haulers than those who have had it just once.

Theres still a lot about SARS-CoV-2, and the bodys response to it, that researchers dont fully understand. Some other microbes, when they reinvade us, can fire up the immune system in unhelpful ways, driving bad bouts of inflammation that burn through the body, or duping certain defensive molecules into aiding, rather than blocking, the viruss siege. Researchers dont think SARS-CoV-2 will do the same. But this pathogen is much more formidable than even someone working on coronaviruses would have expected, Menachery told me. It could still reveal some new, insidious qualities down the line.

Studying reinfection isnt easy: To home in on the phenomenon and its consequences, scientists have to monitor large groups of people over long periods of time, trying to catch as many viral invasions as possible, including asymptomatic ones that might not be picked up without very frequent testing. Seasonal encounters with pathogens other than SARS-CoV-2 dont often worry usbut perhaps thats because were still working to understand their toll. Have we been underestimating long-term consequences from other repeat infections? Thomas said. The answer is probably, almost certainly, yes.

Of the experts I spoke with for this story, several told me they hadnt yet been knowingly infected by SARS-CoV-2; of those who had, none were eager for the sequel. Menachery is in the latter group. He was one of the first people in his community to catch the virus, back in March of 2020, when his entire family fell ill. That November, he discovered that he had lost most of his kidney function, a rapid deterioration that he and his doctors suspect, but cannot prove, was exacerbated by COVID. Menachery received a transplant three months ago, and has been taking immunosuppressive medications sincea major shift to his risk status, and his outlook on reinfection writ large. So I wear my mask everywhere, he told me, as do his wife and their three young kids. Should the virus return for him, its not totally clear what might happen next. Im nervous about reinfection, he said. I have reason to be.

Almost no one can expect to avoid the virus altogether, but that doesnt mean we cant limit our exposures. Its true that the bodys bulwarks against infection tend to erode rather rapidly; its true that this virus is very good at splintering into variants and subvariants that can hop over many of the antibodies we make. But the rhythm of reinfection isnt just about the durability of immunity or the pace of viral evolution. Its also about our actions and policies, and whether they allow the pathogen to transmit and evolve. Strategies to avoid infectionto make it as infrequent as possible, for as many people as possibleremain options, in the form of vaccination, masking, ventilation, paid sick leave, and more. There are still very good reasons to keep exposures few and far between, Landon, of the University of Chicago, told me. Putting off reinfection creates fewer opportunities for harm: The dice are less likely to land on severe disease (or chronic illness) when theyre rolled less often overall. It also buys us time to enhance our understanding of the virus, and improve our tools to fight it. The more we know about COVID when we get COVID, the better off well be, she said.

Read: The coronaviruss next move

SARS-CoV-2 may yet become another common-cold coronavirus, no more likely to screw with its hosts the fifth time it infects them than the first. But thats no guarantee. The outlooks of the experts I spoke with spanned the range from optimism to pessimism, though all agreed that uncertainty loomed. Until we know more, none were keen to gamble with the virusor with their own health. Any reinfection will likely still pose a threat, even if its not the worst-case scenario, Abdool Karim told me. I wouldnt want to put myself in that position.

Read the original:

You Are Going to Get COVID Again And Again And Again - The Atlantic

North Korea tests rivers, air, garbage as anti-COVID efforts gather steam – Reuters.com

May 28, 2022

SEOUL, May 27 (Reuters) - North Korean health officials are testing rivers, lakes, the air and household wastewater and garbage for the coronavirus as the country intensifies its fight against its first outbreak, state media said on Friday.

The isolated country has been in a heated battle against an unprecedented COVID wave since declaring a state of emergency and imposing a nationwide lockdown this month, fuelling concerns about a lack of vaccines, medical supplies and food shortages.

State media said authorities are stepping up testing and disinfection across the country, after reporting this week a "stabilising" trend in the outbreak, including signs that the a wave of fevers was abating and a relatively low death toll. read more

Register

Some 100,460 more people showed fever symptoms as of Thursday evening, compared with nearly 400,000 about 10 days ago, the official KCNA news agency said, citing data from the state emergency epidemic prevention headquarters.

The total number of fever patients since April rose to 3,270,850 among the 25 million population, and a death toll to 69, up by one from a day earlier.

In another dispatch, KCNA said anti-virus offices gathered samples from many sources to check whether areas had been infected with COVID-19.

"Emergency anti-epidemic sectors at all levels give precedence to the test of specimens collected in rivers and lakes, while disinfecting hundreds of thousands of cubic meters of sewage and thousands of tons of garbage every day and examining and analysing samples," KCNA said.

It did not elaborate on testing methods. North Korea said last year it had developed its own polymerase chain reaction (PCR) test equipment, but has never confirmed how many people have tested positive, instead reporting the number with fever symptoms.

Experts have said those figures could be underreported, and make it difficult to assess the scale of the situation. read more

A video provided by KCNA showed a group of officials wearing protective clothing and medical masks conveying boxes with signs saying "specimen carrier" or "bacteria, virus tester."

Reuters was unable to independently verify information contained in the video.

"Officials are collecting samples from people showing fever ... and testing drinks produced at water factories in Pyongyang to ensure they are clean and safe," Jo Chol Ung, vice chief of the Pyongyang Municipal Hygienic and Anti-epidemic Centre, said in the footage.

Register

Reporting by Hyonhee Shin; Additional reporting by Minwoo Park and Joori Roh; Editing by Leslie Adler and Gerry Doyle

Our Standards: The Thomson Reuters Trust Principles.

Read more here:

North Korea tests rivers, air, garbage as anti-COVID efforts gather steam - Reuters.com

Monkeypox and COVID-19 are different in a good way – NPR

May 26, 2022

Spallanzani infectious disease hospital Director Francesco Vaia talks to reporters at the end of a news conference Friday in Rome. Andrew Medichini/AP hide caption

Spallanzani infectious disease hospital Director Francesco Vaia talks to reporters at the end of a news conference Friday in Rome.

The recent headlines about a sudden emergence of an unusual disease, spreading case by case across countries and continents may, for some, evoke memories of early 2020.

But monkeypox is no COVID-19 in a good way.

Health officials worldwide have turned their attention to a new outbreak of monkeypox, a virus normally found in central and west Africa that has appeared across Europe and the U.S. in recent weeks even in people who have not traveled to Africa at all.

But experts say that, while it's important for public health officials to be on the lookout for monkeypox, the virus is extremely unlikely to spin out into an uncontrolled worldwide pandemic in the same way that COVID-19 did.

"Let's just say right off the top that monkeypox and COVID are not the same disease," said Dr. Rosamund Lewis, head of Smallpox Secretariat at the World Health Organization, at a public Q&A session on Monday.

For starters, monkeypox spreads much less easily than COVID-19. Scientists have been studying monkeypox since it was first discovered in humans more than 50 years ago. And its similarities to smallpox mean it can be combated in many of the same ways.

As a result, scientists are already familiar with how monkeypox spreads, how it presents, and how to treat and contain it giving health authorities a much bigger head start on containing it.

Here are some of the other ways the public health approach to monkeypox is different from COVID-19:

Monkeypox typically requires very close contact to spread most often skin-to-skin contact, or prolonged physical contact with clothes or bedding that was used by an infected person.

By contrast, COVID-19 spreads quickly and easily. Coronavirus can spread simply by talking with another person, or sharing a room, or in rare cases, being inside a room that an infected person had previously been in.

"Transmission is really happening from close physical contact, skin-to-skin contact. It's quite different from COVID in that sense," said Dr. Maria Van Kerkhove, an infectious disease epidemiologist with the WHO.

The classic symptom of monkeypox is a rash that often begins on the face, then spreads to a person's limbs or other parts of the body.

"The incubation from time of exposure to appearance of lesions is anywhere between five days to about 21 days, so can be quite long," said Dr. Boghuma Kabisen Titanji, an infectious disease physician and virologist at Emory University in Atlanta.

The current outbreak has seen some different patterns, experts say particularly, that the rash begins in the genital area first, and may not spread across the body.

Either way, experts say, it is typically through physical contact of that rash that the virus spreads.

"It's not a situation where if you're passing someone in the grocery store, they're going to be at risk for monkeypox," said Dr. Jennifer McQuiston of the Centers for Disease Control and Prevention, in a briefing Monday.

The people most likely to be at risk are close personal contacts of an infected person, such as household members or health care workers who may have treated them, she said.

"We've seen over the years that often the best way to deal with cases is to keep those who are sick isolated so that they can't spread the virus to close family members and loved ones, and to follow up proactively with those that a patient has contact with so they can watch for symptoms," McQuiston said.

With this version of virus, people generally recover in two to four weeks, scientists find, and the death rate is less than 1%.

One factor that helped COVID-19 spread rapidly across the globe was the fact that it is very contagious. That's even more true of the variants that have emerged in the past year.

Epidemiologists point to a disease's R0 value the average number of people you'd expect an infected person to pass the disease along to.

For a disease outbreak to grow, the R0 must be higher than 1. For the original version of COVID-19, the number was somewhere between 2 and 3. For the omicron variant, that number is about 8, a recent study found.

Although the recent spread of monkeypox cases is alarming, the virus is far less contagious than COVID-19, according to Jo Walker, an epidemiologist at Yale School of Public Health.

"Most estimates from earlier outbreaks have had an R0 of less than one. With that, you can have clusters of cases, even outbreaks, but they will eventually die out on their own," they said. "It could spread between humans, but not very efficiently in a way that could sustain itself onward without constantly being reintroduced from animal populations."

That's a big reason that public health authorities, including the WHO, are expressing confidence that cases of monkeypox will not suddenly skyrocket. "This is a containable situation," Van Kerkhove said Monday at the public session.

Monkeypox and smallpox are both members of the Orthopox family of viruses. Smallpox, which once killed millions of people every year, was eradicated in 1980 by a successful worldwide campaign of vaccines.

The smallpox vaccine is about 85% effective against monkeypox, the WHO says, although that effectiveness wanes over time.

"These viruses are closely related to each other, and now we have the benefit of all those years of research and diagnostics and treatments and in vaccines that will be brought to bear upon the situation now," said Lewis of the WHO.

Some countries, including the U.S., have held smallpox vaccines in strategic reserve in case the virus ever reemerged. Now, those can be used to contain a monkeypox outbreak.

The FDA has two vaccines already approved for use against smallpox.

One, a two-dose vaccine called Jynneos, is also approved for use against monkeypox. About a thousand doses are available in the Strategic National Stockpile, the CDC says, and the company will provide more in the coming months.

"We have already worked to secure sufficient supply of effective treatments and vaccines to prevent those exposed from contracting monkeypox and treating people who've been affected," said Dr. Raj Panjabi of the White House pandemic office, in an interview with NPR.

Link:

Monkeypox and COVID-19 are different in a good way - NPR

Are UK coronavirus cases actually going down or are they just harder to count? – The Guardian

May 26, 2022

How can we tell how high cases are when people have stopped testing?

For almost two years weve been glued to a set of numbers: the grim trio of cases, hospitalisations and deaths that defined coronavirus in the UK.

The daily figures led news reports for more than a year: people watched in horror as the height of the Omicron wave brought the highest ever daily caseload on Tuesday 4 January 2022 when 275,618 people tested positive. And they saw how many people died: a number that peaked on Tuesday 19 January 2021, when 1,366 people died, making it the the worst day of the pandemic*.

Since March 2022 case numbers from the daily government dashboard have tumbled. A fall that has coincided with the governments Living with Covid plan: as restrictions fell away in England, so did cases. The government ended restrictions including the legal requirement to self-isolate on 24 February and cut the provision of free tests on 1 April.

After two long years of disease, restrictions and fear its the news everyone has been hoping for.

But have cases really gone down that fast?

Like all statistics the UKs coronavirus statistics are a way of measuring something but not the thing itself.

Its not hard to see that as the government cut free NHS tests and people werent able to report private tests, the total number of tests fell, and so did the number of positive tests. Then, by the governments measurements at least, cases fell.

And falling cases made it look like the government was justified to cut tests.

The good news? Cases are on a downward trend. But it hasnt been as fast or as rosy as the government charts have made out.

Looking at the weekly coronavirus infection survey from the Office for National Statistics (ONS) puts the recent fall in perspective.

What the government (coronavirus.gov.uk) case numbers actually measure is not the number of of new people in the UK infected with coronavirus every day. But, the number of people who take a test, get a positive test result, and then report that test.

Throughout most of the pandemic, government numbers were recording about a third of the cases that the ONS was picking up.

Instead of relying on people choosing to take a test, the ONS numbers are estimates based on a sample of around 200,000 people across the UK who take a test every month regardless of whether they have symptoms. This makes the ONS system better at catching asymptomatic infections, and better at picking up milder variants like Omicron.

However the ending of free tests sees that relationship break down with the gov.uk figures almost entirely missing the March 2022 spike and recording less than a twelfth of the cases that the ONS picked up at the start of April

But the overall picture is positive. On all measures cases are down. Vaccination levels are high, antibody levels are high, and the spread of infectious disease tends to reduce in the summer. But that wont last for ever.

In all four scenarios considered by the Scientific Advisory Group for Emergencies of how the pandemic will unfold, there is a resurgence in the autumn/winter of 2022. In the best case, it is a small one.

Given that this will happen, it is vital to maintain virus surveillance system and the ability to ramp up protection measures again, as Sir Patrick Vallance, the UK governments chief scientific adviser, argued at the launch of the Living With Covid plan.

But the warning system doesnt have to come from the daily numbers we have got used to on the government dashboard. Prof Kevin McConway argues that daily cases numbers from the gov.uk dashboard were always more about news cycles than actual health surveillance.

The data from tests did help, but the numbers and rates were always subject to biases of unknown size, because they depended on who was turning up to be tested, he says. That varied some people had jobs that required frequent testing, and those requirements changed over time; some people might not choose to be tested even if they knew, or suspected, they had symptoms because they would lose their income; at a few times tests were difficult to get.

Even before people had to turn to private tests on 1 April, we see a big dip in testing showing a change in attitude to the virus, as much as people reacting to the price change.

UK testing peaked in January 2022

Registered coronavirus test results and number that are positive, by date of publication. 5 April 2020 had the highest percentage of positive test results. 4 January 2022 had the highest number of registered tests. *From 26th Feb 2022: no case data is published on Saturdays or Sundays and figures published on Monday include three days' data, so case data is removed from this label on these days to allow for accurate comparisions over time. Test data continues to be reported as normal over the weekend. Data: data.gov.uk. updated

Even if free tests were still available now, peoples propensity to ask for them would have changed a lot because of the perception that the disease isnt as important or dangerous as it was, says McConway. That partly stems from government policies and announcements but by no means all of it it would have happened anyway.

The UK Health Surveillance Agency (UKSHA), which has taken over from Public Health England, is continuing to publish Flu and Covid-19 Surveillance reports that draw together data sources including the ONS infection survey but also information from GPs and hospitals, places outside the health system such as care homes and schools, and even sources such as Google searches for symptoms and reports of disease outbreaks at workplaces like restaurants.

More creative data sources such as sewage have even been used to gauge coronavirus levels in the population. Though are not currently referenced in the surveillance report.

The emergence of a more transmissible or more deadly variant is one of the key areas of concern for next winter so continued genomic sequencing of samples is required to keep track of how the virus is mutating. And blood samples will continue to be needed as antibody levels give an indication of immunity.

McConway says the UK has decent measures in place to keep track of diseases that get less media attention than coronavirus.

Whats unique about Sars-CoV-2 is the scale of the pandemic, and the public and government and media interest, and some of that led to different and more elaborate and expensive surveillance approaches, but lots of things go on all the time without most people noticing.

So as with flu it is likely authorities will see the warning signs before a new surge hits in the winter. The question is then as Vallance notes whether the government will act on it.

The Guardians UK coronavirus tracker will switch over shortly to use ONS infection survey numbers for cases, instead of the gov.uk numbers

Notes:

* Gov.uk counted 275,618 new cases by specimen date on 4 January 2022 in the UK the highest daily caseload for the pandemic. The date with the highest number of cases by date reported was also the 4 January 2022 with 218,724 new cases (for the period when the government was publishing figures daily).

Gov.uk counted 1,366 deaths within 28 days of a positive test by date of death on 19 January 2021, in the UK. The worst day for deaths by date reported within 28 days of a positive test in the UK is 20 Jan 2021, when 1,820 deaths were reported.

Continued here:

Are UK coronavirus cases actually going down or are they just harder to count? - The Guardian

Will the Coronavirus Pandemic Ever End? – The New Yorker

May 24, 2022

Twenty-seven months into the COVID-19 pandemic, our defenses against the coronavirus seem at once stronger and more penetrable than ever. A growing majority of the U.S. population now has some immunity to SARS-CoV-2, the virus that causes COVID-19, whether from vaccination, past infection, or both. However, staggeringly infectious members of the Omicron family have demonstrated an ability to evade some of those protections. Since April, they have led to a quadrupling of daily coronavirus cases; the U.S. has been reporting more than a hundred thousand a day, but, because widely used at-home tests dont show up in official tallies, the true number could be five or even ten times higher.

When the original Omicron, BA.1, swept the country this winter, it was by far the most contagious variant to date. But a subvariant that emerged more recently, BA.2, appears to be thirty per cent more transmissible, and one of its descendants, BA.2.12.1, is more contagious still. Unfortunately, people who have recovered from BA.1 infections can be reinfected by Omicron subvariants. According to some estimates, the U.S. could see a hundred million coronavirus infections this fall and winter. This is approaching one of the most transmissible pathogens in history, Eric Topol, the director of the Scripps Research Translational Institute, told me.

Yet the countrys response has been one of indifference. No state currently requires masks in public places, even though the director of the Centers for Disease Control and Prevention has said that a third of Americans should consider wearing them, and New York City recently recommended them indoors. When a judge struck down a federal mask requirement for trains and airplanes, the Biden Administration appealed, but did not seek to immediately reinstate the mandate. In April, less than a third of Americans said that they were even somewhat worried about getting COVID-19, the lowest proportion since July, 2021, and fewer people were socially distancing than at any time during the pandemic. A third of the population believes that the pandemic is over, including more than half of unvaccinated Americans and nearly six in ten Republicans.

This attitude is attributable, in part, to an indisputable reduction in the most serious consequences of COVID-19. Although new variants are causing more breakthrough infections, vaccines remain protective against severe illness. During the current surge, COVID deaths have been steady at around three hundred a daystill too many, but near pandemic lowsand hospitalizations have risen modestly. But our apathy also seems related to a pandemic malaisean inability or unwillingness to devote more cognitive and material resources to a problem that refuses to leave us alone. Congress has so far failed to fund an adequate supply of vaccines, tests, and treatments this winter, suggesting that the country has retreated not only from controversial mandates but from the most basic tools of public health.

As a physician, I have struggled to know what to make of this moment in the pandemic, and I fear that it will last a long time. We may be in this phase forever, Robert Wachter, the chair of the department of medicine at the University of California, San Francisco, told me. Lately, Ive been seeking out people who have shaped the COVID discourseexperts who have not only shared and interpreted information but helped to construct a pandemic narrative and, in doing so, influenced policymakers and the public. I wanted to understand how their thinking has changed on key questions now facing the country: How should we live? Who should decide? How long will this last? As the coronavirus has become less deadly yet more difficult to contain, they told me, strategies that defined the early pandemic have fallen away, and responsibility for our everyday behavior has shifted away from public-health officials and toward individuals. In the coming months, well learn the consequences of this approach.

Doctors often categorize medical conditions as acute, subacute, or chronic. A patient with crushing chest pain and an alarming EKG is experiencing an acute emergency, meaning that, within minutes, they need a specific series of drugs and a team of medical professionals to unclog the culprit blood vessel. Another patient may feel his chest tighten when he walks up stairs, but the discomfort fades when he rests, and its been this way for years. His angina is said to be chronic: its serious and needs medical attention, but can usually be managed with medications and checkups. The subacute condition is somewhere in between. Last month, a man could climb three flights; last week, only two; and today, his torso feels heavy when he walks to the bathroom. Subacute illnesses are hazardous in their own way. They can often be mitigated if treated appropriately, but they may be difficult to diagnose, and, if you ignore or mismanage them, they can spiral out of control.

I sometimes think of this period as a subacute phase of the pandemic. COVID-19 is no longer an acute emergency, but its not yet clear how it will become an endemic disease that we are ready to live with. Public weariness, highly transmissible variants that evade some of our immunitythese factors may condemn us to intermittent surges long into the future. Within the realm of my imagination, I can no longer see a true game changer that alters the fundamental dynamics from where we are today, Wachter told me. For me to say otherwise would be some combination of wishful thinking and reacting to my own internal pressure, and pressure from those around me, not to be a bummer. This is, of course, a bummer. Still, it might not be as bad as it sounds. Were not going to see another million COVID deaths in the United States, Wachter said. The vast majority of severe illness will be fully preventable. Well probably wear masks in some places, maybe get regular boosters. Its not the end of the world. It doesnt diminish my life significantly.

The experts I spoke to seemed to accept that, as a society, our options for containing such a transmissible virus are limited. If cases were falling and there were not new variants that are so highly contagious, then suppressing infection would actually be a viable path, Leana Wen, the former health commissioner of Baltimore, told me. We have to recognize that the price of prioritizing low infection rates would be astronomical. In her view, the U.S. cant afford to close schools, restrict travel, or shutter businesses for long periods, and those stringent measures might not work anyway. Even China, with the strictest lockdown in the world, is struggling to contain these hyper-contagious variants, Devi Sridhar, a professor of public health at the University of Edinburgh and the author of Preventable: How a Pandemic Changed the World and How to Stop the Next One, told me. We have to pivot away from the idea that we can avoid getting infected.

Wen once advocated for strict measures to suppress the virus, but now argues for a return to something like normal life. She told me that she changed her mind in part because infections have grown less punishing with time, as more people acquire immunity and gain access to effective drugs. In two years, the infection fatality rate of SARS-CoV-2 has fallen dramatically. For people whove received a booster shot, it now really is on par with the flu. (Of course, the coronavirus is still infecting a lot more people.) As the risk of severe COVID-19 falls, Wen said, the threshold for policymakers to impose restrictions should rise. She argued that mandates would become appropriate only if a new and deadlier variant emerges. Reintroducing them now would erode trust in public health and weaken our ability to respond to future emergencies, she said. As soon as the emergency fades, individual choice is again the key decider.

Wen frequently hears the criticism, sometimes in the form of online vitriol, that her position does not fully account for the roughly seven million Americans who remain at higher risk for serious COVID-19, even after vaccination, because of compromised immune systems. Although she thinks that more should be done to protect the immunocompromised, she also believes that most Americans should be allowed to return to their pre-pandemic routines. In my clinical practice, I often care for immunocompromised patients who express fear and frustration that the country seems determined to move on from the pandemicand, in their minds, to leave them behind. Having treated the devastating consequences of infections in these patients, I find it hard not to empathize with them, and I dont have easy answers. Wachter told me that he is sympathetic to the idea that were not doing enough to protect vulnerable peoplebut in a country where many people dont even have access to medical care, he said, the idea that, all of a sudden, everyone in society is going to do everything possible... that strikes me as seeking a perfect world that were awfully far from. In his view, most immunocompromised people now have the tools to keep themselves relatively safe. He pointed to vaccines, boosters, antivirals, N95 masks, and Evusheld, a preventive monoclonal antibody authorized for people who are moderately or severely immunocompromised. And, of course, we should all be encouraged to get tested and mask up before we spend time with someone whos at high risk of a serious infection.

If were all likely to get COVID at some point, should everyone still try to avoid it? Wachter thinks so, and called for individuals to take precautionsmasks, tests, steering clear of large indoor gatheringsin places where the coronavirus is highly prevalent. For me at least, the long-COVID risk makes the benefits of reasonable amounts of caution outweigh the downsides, but I could see others making different choices, he told me. In the future, antivirals are likely to get better. Vaccines may be better. Well understand more about long COVID and how to manage it. At some point in my life, I know Im going to get some terrible disease, whether COVID or something else. Id like it to be as far down the road as possible. He pointed to a recent estimate from the C.D.C. that nearly sixty per cent of Americans have been infected by the coronavirus, which suggests that more than a hundred million Americans have not.

The virus will continue to evolve, but so will our tools for fighting it. Its going to be innovation, not behavior change, that gets us out of this mess, Topol, the Scripps director, told me. You cant keep people in a cave forever. Topol fears that a future variant will be more virulent. It pains me to say it, because Im an optimist, he said. But he argued that the U.S. still has the power to change the course of the pandemic, by continuing to invest in scientific research.

So far, new variants have tended to become more transmissible and better at getting around our immune defenses, but not more lethal. This makes sense from an evolutionary perspectivethe virus faces selective pressure to find new ways to spread, not killand SARS-CoV-2 could go the way of other coronaviruses that cause the common cold. Then again, it might not. People have this delusional idea that somehow the variants are just going to get milder over timewrong! Topol said. They could easily become more pathogenic. He pointed out that, compared with prior variants, Omicron has spawned more subvariants, which are chipping away at the immunity wall of vaccination.

In addition to advances such as better antiviral drugs, several types of vaccine innovations would be especially valuable. The first is a universal coronavirus vaccine. Such a vaccine could potentially give us some immunity against all SARS-CoV-2 variants, as well as other coronaviruses. (A research group at the California Institute of Technology, for example, has used a vaccine platform called a mosaic nanoparticle, which incorporates proteins from up to eight types of coronaviruses and has shown promising results in mice.) A second transformative innovation would be a vaccine that produces sterilizing immunitythat is, in its ideal form, an antibody response so potent that it prevents the pathogen from infecting and reproducing within us at all. This would dramatically slow the spread of the virus, but, for COVID-19 and many other pathogens, sterilizing vaccines have remained elusive. A vaccine thats sprayed into the nose might be one path toward something closer to it. Because nasal vaccines produce high levels of antibodies inside the nose, where the virus often enters the body, they could be more effective at preventing infection altogether. There are now three such vaccine candidates in late-stage clinical trials; they present the body with many viral proteins, not just the spike, and could therefore produce broad, variant-resistant immunity. Many people have needle-phobia and would probably say, I dont want any more booster shots, but I wouldnt mind taking a nasal spray every four-to-six months, Topol told me. We should be getting the nose and mouth Teflon-coated. Hes troubled by a profound lack of investment in these kinds of advances.

Continued here:

Will the Coronavirus Pandemic Ever End? - The New Yorker

Hospitalizations on the rise as Utah COVID-19 case counts jump more than 33% in past week – The Spectrum

May 24, 2022

Mike Stucka USA TODAY NETWORK| St. George Spectrum & Daily News

New coronavirus cases leaped in Utah in the week ending Sunday, rising 33.1% as 4,504 cases were reported. The previous week had 3,385 new cases of the virus that causes COVID-19.

Utah ranked 31st among the states where coronavirus was spreading the fastest on a per-person basis, a USA TODAY Network analysis of Johns Hopkins University data shows. In the latest week coronavirus cases in the United States increased 31.8% from the week before, with 796,108 cases reported. With 0.96% of the country's population, Utah had 0.57% of the country's cases in the last week. Across the country, 42 states had more cases in the latest week than they did in the week before.

More: COVID-19 case rates are rising again in Utah. Here is what healthcare leaders think that means

Within Utah, the worst weekly outbreaks on a per-person basis were in Summit County with 301 cases per 100,000 per week; Salt Lake County with 205; and Wasatch County with 153. The Centers for Disease Control says high levels of community transmission begin at 100 cases per 100,000 per week.

Adding the most new cases overall were Salt Lake County, with 2,374 cases; Utah County, with 655 cases; and Davis County, with 473. Weekly case counts rose in six counties from the previous week. The worst increases from the prior week's pace were in Salt Lake, Davis and Utah counties.

>> See how your community has fared with recent coronavirus cases

Utah ranked 28th among states in share of people receiving at least one shot, with 72.1% of its residents at least partially vaccinated. The national rate is 77.7%, a USA TODAY analysis of CDC data shows. The Pfizer and Moderna vaccines, which are the most used in the United States, require two doses administered a few weeks apart.

In the week ending Wednesday, Utah reported administering another 26,848 vaccine doses, including 3,326 first doses. In the previous week, the state administered 10,967 vaccine doses, including 1,555 first doses. In all, Utah reported it has administered 5,212,257 total doses.

In Utah, four people were reported dead of COVID-19 in the week ending Sunday. In the week before that, one person was reported dead.

A total of 943,368 people in Utah have tested positive for the coronavirus since the pandemic began, and 4,765 people have died from the disease, Johns Hopkins University data shows. In the United States 83,281,329 people have tested positive and 1,002,173 people have died.

>> Track coronavirus cases across the United States

USA TODAY analyzed federal hospital data as of Sunday, May 22.

Likely COVID patients admitted in the state:

Likely COVID patients admitted in the nation:

Hospitals in 31 states reported more COVID-19 patients than a week earlier, while hospitals in 29 states had more COVID-19 patients in intensive-care beds. Hospitals in 37 states admitted more COVID-19 patients in the latest week than a week prior, the USA TODAY analysis of U.S. Health and Human Services data shows.

The USA TODAY Network is publishing localized versions of this story on its news sites across the country, generated with data from Johns Hopkins University and the Centers for Disease Control. If you have questions about the data or the story, contact Mike Stucka at mstucka@gannett.com.

The rest is here:

Hospitalizations on the rise as Utah COVID-19 case counts jump more than 33% in past week - The Spectrum

Page 321«..1020..320321322323..330340..»